Preclinical studies propose that retatrutide may perhaps influence obesity-linked most cancers development. In a research led by Marathe et al., retatrutide-induced weight-loss minimized tumor engraftment, delayed tumor onset, and significantly attenuated tumor development in pancreatic and lung cancer types, with larger tumor suppression than the